Aldeyra Therapeutics, Inc. (ALDX): EPS (Basic)
-$0.56
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.56 | n/m | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | -$0.94 | n/m | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | -$0.64 | n/m | 2025-02-28, From 2023-01-01 |
| 2022-12-31 | -$1.06 | n/m | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | -$1.07 | n/a | 2023-03-09, From 2021-01-01 |
| No annual figure between 2015-12-31 and 2021-12-31. | |||
| 2015-12-31 | -$1.40 | n/m | 2016-03-30, From 2015-01-01 |
| 2014-12-31 | -$2.51 | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $3.49 | n/a | 2015-03-23, From 2013-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Aldeyra Therapeutics, Inc. (ALDX) | 2025-12-31 | -$0.56 | n/m |
| Corvus Pharmaceuticals, Inc. (CRVS) | 2025-12-31 | -$0.19 | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | -$1.81 | n/m |
| Werewolf Therapeutics, Inc. (HOWL) | 2025-12-31 | -$1.32 | n/m |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $0.15 | n/m |
| Context Therapeutics Inc. (CNTX) | 2025-12-31 | -$0.38 | n/m |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | -$0.19 | n/m |
| Grace Therapeutics, Inc. (GRCE) | 2026-03-31 | -$0.47 | n/m |
| Adagene Inc. (ADAG) | 2025-12-31 | -$0.30 | n/m |
Compare ALDX, CRVS, INO, HOWL side by side · Screen every company in Pharmaceutical Preparations ↗